Home » Stocks » PGNY

Progyny, Inc. (PGNY)

Stock Price: $47.28 USD -1.30 (-2.68%)
Updated Jan 21, 2021 4:00 PM EST - Market closed
Pre-market: $46.50 -0.78 (-1.65%) Jan 22, 7:49 AM
Market Cap 4.10B
Revenue (ttm) 309.68M
Net Income (ttm) 3.20M
Shares Out 86.27M
EPS (ttm) -0.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $47.28
Previous Close $48.58
Change ($) -1.30
Change (%) -2.68%
Day's Open 48.93
Day's Range 47.20 - 48.93
Day's Volume 757,030
52-Week Range 16.47 - 48.93

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 2 days ago

This fertility stock could have serious long-term potential.

InvestorPlace - 3 days ago

Nio, BlackBerry, Tilray, Five9 and Progyny were our top stock trades for Tuesday. Let's check out the charts after a long holiday weekend.

Other stocks mentioned: BB, NIO, TLRY, FIVN
GlobeNewsWire - 2 months ago

NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United S...

GlobeNewsWire - 2 months ago

NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United S...

Seeking Alpha - 2 months ago

Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha - 2 months ago

Progyny went public in October 2019, raising $130 million. The firm provides fertility and family planning benefit services in the United States.

Zacks Investment Research - 2 months ago

Progyny (PGNY) delivered earnings and revenue surprises of 0.00% and 6.18%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 2 months ago

Shares of Progyny (NASDAQ:PGNY) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 66.67% over the past year to $0.05, which ...

Zacks Investment Research - 2 months ago

Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 2 months ago

NEW YORK, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United S...

Benzinga - 3 months ago

Pharmacy benefits manager Progyny Inc (NASDAQ: PGNY) is trading 8.22% lower on thin volume in the pre-market session on Thursday. The company disclosed in SEC form 4 that TPG Group Holdings, w...

GlobeNewsWire - 3 months ago

Researchers Studied Journey Level Analysis of Progression to Treatment Versus Drop Out in a Large Cohort of Patients with Access to a Defined Fertility Benefit Researchers Studied Journey Leve...

InvestorPlace - 3 months ago

There are a handful of companies with no debt in the stock market, but not all of them are worth a close look. Here are seven that are.

Other stocks mentioned: DKNG, ISRG, LULU, MNST, PINS, FSLY
GlobeNewsWire - 4 months ago

NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the Unite...

The Motley Fool - 4 months ago

Progyny provides employers with fertility benefits to help their employees build families.

GlobeNewsWire - 4 months ago

Livingston Will Continue Reporting to Pete Anevski, Progyny’s President and Chief Operating Officer Livingston Will Continue Reporting to Pete Anevski, Progyny’s President and Chief Operating ...

InvestorPlace - 4 months ago

Growth stocks have been the market's biggest winners. Amid valuation concerns, these 10 stocks still have the potential for 100%-plus gains.

Other stocks mentioned: APHA, CRWD, FSLY, INMD, PINS, REAL, ROKU, SPCE, WORK
Seeking Alpha - 5 months ago

Progyny, Inc's (PGNY) CEO David Schlanger on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 5 months ago

Reports Second Quarter Revenue of $64.6 MillionPatient Return to Treatment Faster Than ExpectedIssues Revenue Guidance of $323.0 to $340.0 Million for Full Year 2020, Reflecting Growth of 41% ...

Seeking Alpha - 5 months ago

Progyny Is Delivering Even During Lockdown

GlobeNewsWire - 5 months ago

NEW YORK, July 22, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United...

Seeking Alpha - 7 months ago

Progyny: In Its Third Trimester And Poised For Healthy Growth

The Motley Fool - 8 months ago

Q1 earnings beat, and Progyny is lining up to do it again in Q2.

Seeking Alpha - 8 months ago

Progyny, Inc. (PGNY) CEO David Schlanger on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 8 months ago

Company Well-Positioned to Successfully Manage COVID-Related Impacts Reports 72% Increase in First Quarter Revenue to $81.0 MillionReports $12.1 Million in Quarterly Operating Cash Flow, Addin...

Investors Business Daily - 8 months ago

Progyny reports earnings after the close today as fertility clinics postpone procedures due to the coronavirus pandemic. The post Progyny Reports Earnings Late As Coronavirus Delays Fertility ...

GlobeNewsWire - 9 months ago

Nasdaq Partners with Progyny to Bring Comprehensive and Inclusive Fertility and Family Building Benefits to its US Employees Nasdaq Partners with Progyny to Bring Comprehensive and Inclusive F...

GlobeNewsWire - 10 months ago

NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the Unite...

Seeking Alpha - 10 months ago

Progyny, Inc. (PGNY) CEO David Schlanger on Q4 2019 Results - Earnings Call Transcript

Investors Business Daily - 10 months ago

Progyny earnings for Q4 are due after the close as the fertility benefits manager begins its selling season. The post Progyny Earnings Are Due Late; Start Of Selling Season Will Clarify Compet...

GuruFocus - 11 months ago

Since entering into the public market last October, shares of Progyny Inc. (NASDAQ:PGNY), a company specializing in providing fertility and family benefits solutions for U.S.

Seeking Alpha - 11 months ago

Progyny: A Growth Stock With A Unique Value Proposition

Investors Business Daily - 1 year ago

Here are five recent IPOs near buy points: XP, Dynatrace, Progyny, Datadog and Bill.com. Three are already turning profits.

Other stocks mentioned: BILL, DDOG, DT
Investors Business Daily - 1 year ago

Dow Backs Off 29,000 Level After Weak Jobs Report

Major stock indexes weakened late Friday, ending with mild losses in light volume.

Other stocks mentioned: DT, XP
The Motley Fool - 1 year ago

Progyny and Zoom Video stocks are zooming.

Other stocks mentioned: ZM
Forbes - 1 year ago

Progyny (NASDAQ: PGNY), is a benefits management company that specializes in fertility and family building benefits solutions. The company’s stock is up 90% since its listing in late October, ...

Investors Business Daily - 1 year ago

IPO stocks Dynatrace, Datadog, Progyny, Ping Identity and Starbucks rival Luckin Coffee are all near buy points. But handle IPOs with care.

Other stocks mentioned: DDOG, DT, LK, PING
The Motley Fool - 1 year ago

This new IPO beat earnings in its first report.

Investors Business Daily - 1 year ago

Stocks Rip Higher On Strong Jobs Report

News of better than expected job growth in November fueled another rally on Wall Street Friday.

Other stocks mentioned: DOCU, ZUMZ
Seeking Alpha - 1 year ago

Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2019 Results - Earnings Call Transcript

Investors Business Daily - 1 year ago

Fertility benefits manager and recent IPO Progyny reports third-quarter earnings after the close as the stock sets up in a base.

Investors Business Daily - 1 year ago

Salesforce.com, Dollar General, Marvell Technology, Synopsys and hot IPO Progyny are near buy points with earnings on tap. The post Salesforce, Dollar General, Progyny Lead 5 Stocks Near Buys...

Other stocks mentioned: CRM, DG
Investors Business Daily - 1 year ago

Stocks Fall In Short Day; Progyny, Adobe, Salesforce Near Buy Points

Stocks Fall In Short Day; Progyny, Adobe, Salesforce Near Buy Points.

Other stocks mentioned: ADBE, CRM
GlobeNewsWire - 1 year ago

New York, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United...

GlobeNewsWire - 1 year ago

New York, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United...

GuruFocus - 1 year ago

According to these filters, the following are significant trades from company insiders this month.

Other stocks mentioned: BLPH, BRP, CMCSA, OPK, STON
Seeking Alpha - 1 year ago

Progyny Inc.: Great Business, Absurd Valuation

GlobeNewsWire - 1 year ago

NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Progyny, Inc., a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today ...

Forbes - 1 year ago

Progyny Inc., the fertility and family building benefits company that serves US employers like Google, Apple, announced its Initial Public Offering of 10,000,000 shares at a price of $13.00 pe...

Forbes - 1 year ago

Progyny Inc., the fertility and family building benefits company that serves US employers like Google, Apple, announced its Initial Public Offering of 10,000,000 shares at a price of $13.00 pe...

About PGNY

Progyny, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption expenses for clie... [Read more...]

Industry
Health Information Services
IPO Date
Oct 25, 2019
CEO
David J. Schlanger
Employees
167
Stock Exchange
NASDAQ
Ticker Symbol
PGNY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Progyny stock is "Buy." The 12-month stock price forecast is 47.75, which is an increase of 0.99% from the latest price.

Price Target
$47.75
(0.99% upside)
Analyst Consensus: Buy